Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine

More than 70 million people worldwide are infected with hepatitis C virus, a major cause of liver cirrhosis, liver failure and hepatocellular carcinoma world-wide. In the last decade, this cancer has emerged as the second leading cause of cancer death and the global burden is increasing by two milli...

Full description

Saved in:
Bibliographic Details
Superior document:Frontiers Research Topics
:
Year of Publication:2019
Language:English
Series:Frontiers Research Topics
Physical Description:1 electronic resource (128 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993544176404498
ctrlnum (CKB)4920000000094316
(oapen)https://directory.doabooks.org/handle/20.500.12854/44424
(EXLCZ)994920000000094316
collection bib_alma
record_format marc
spelling Thomas F. Baumert auth
Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
Frontiers Media SA 2019
1 electronic resource (128 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Frontiers Research Topics
More than 70 million people worldwide are infected with hepatitis C virus, a major cause of liver cirrhosis, liver failure and hepatocellular carcinoma world-wide. In the last decade, this cancer has emerged as the second leading cause of cancer death and the global burden is increasing by two million new infections per year, mainly due to injection drug use. An effective vaccine will be the most effective means to contain the spread of this virus worldwide. The articles in this Research Topic describe the progress that has been made towards a preventive vaccine and the challenges that still need to be overcome to ultimately achieve this goal.
English
Conformational epitopes
humoral immunity
Conformational structures
neutralizing antibodies
Vaccine
Hepatitis C virus
hypervariability and flexibility
2-88945-714-1
Steven K.H. Foung auth
language English
format eBook
author Thomas F. Baumert
spellingShingle Thomas F. Baumert
Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
Frontiers Research Topics
author_facet Thomas F. Baumert
Steven K.H. Foung
author_variant t f b tfb
author2 Steven K.H. Foung
author2_variant s k f skf
author_sort Thomas F. Baumert
title Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
title_full Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
title_fullStr Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
title_full_unstemmed Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
title_auth Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
title_new Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
title_sort current progress and challenges in the development of a hepatitis c virus vaccine
series Frontiers Research Topics
series2 Frontiers Research Topics
publisher Frontiers Media SA
publishDate 2019
physical 1 electronic resource (128 p.)
isbn 2-88945-714-1
illustrated Not Illustrated
work_keys_str_mv AT thomasfbaumert currentprogressandchallengesinthedevelopmentofahepatitiscvirusvaccine
AT stevenkhfoung currentprogressandchallengesinthedevelopmentofahepatitiscvirusvaccine
status_str n
ids_txt_mv (CKB)4920000000094316
(oapen)https://directory.doabooks.org/handle/20.500.12854/44424
(EXLCZ)994920000000094316
carrierType_str_mv cr
hierarchy_parent_title Frontiers Research Topics
is_hierarchy_title Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
container_title Frontiers Research Topics
author2_original_writing_str_mv noLinkedField
_version_ 1796649061286150144
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01772nam-a2200361z--4500</leader><controlfield tag="001">993544176404498</controlfield><controlfield tag="005">20231214133454.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2019 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000000094316</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/44424</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000000094316</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Thomas F. Baumert</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (128 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">More than 70 million people worldwide are infected with hepatitis C virus, a major cause of liver cirrhosis, liver failure and hepatocellular carcinoma world-wide. In the last decade, this cancer has emerged as the second leading cause of cancer death and the global burden is increasing by two million new infections per year, mainly due to injection drug use. An effective vaccine will be the most effective means to contain the spread of this virus worldwide. The articles in this Research Topic describe the progress that has been made towards a preventive vaccine and the challenges that still need to be overcome to ultimately achieve this goal.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Conformational epitopes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">humoral immunity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Conformational structures</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neutralizing antibodies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Vaccine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Hepatitis C virus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hypervariability and flexibility</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88945-714-1</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Steven K.H. Foung</subfield><subfield code="4">auth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:55:04 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-11-10 04:18:40 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337555480004498&amp;Force_direct=true</subfield><subfield code="Z">5337555480004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337555480004498</subfield></datafield></record></collection>